Children's Health Defense By
A Louisiana woman who sued the manufacturers of popular diabetes and weight loss drugs Ozempic and Mounjaro is alleging the drugmakers failed to warn the public about the risk of severe gastrointestinal problems.
Jaclyn Bjorklund, 44, who on Wednesday filed the 26-page lawsuit in U.S. District Court for the Western District of Louisiana Lake Charles Division, claims she was “severely injured” after taking the two medications.
According to the complaint, Novo Nordisk and Eli Lilly, the manufacturers of Ozempic and Mounjaro, respectively, “downplayed the severity of the gastrointestinal events,” such as gastroparesis and gastroenteritis, caused by the drugs.
Gastroparesis, a disorder that “slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage in the stomach or intestines” is frequently caused by diabetes. Narcotics and antidepressants also are linked to gastroparesis…
